
FDA Approves Drug That Doubles Pancreatic Cancer Survival
A newly approved pill nearly doubles survival time for patients with advanced pancreatic cancer, offering real hope for one of the deadliest cancer types. The breakthrough targets a protein that drives tumor growth in 95% of pancreatic cancer cases.
















%3Amax_bytes(150000)%3Astrip_icc()%2F2208-05-074_cattle-0930040062ba48a497b4d462c206b168.jpg)